icon-    folder.gif   Conference Reports for NATAP  
 
  11th IAS Conference on HIV Science 18-21 July 2021
Back grey_arrow_rt.gif
 
 
 
Long-acting subcutaneous lenacapavir dosed every 6 months as part of a combination regimen in treatment-naïve people with HIV: interim 16-week results of a randomized, open-label, phase 2 induction-maintenance study (CALIBRATE)
 
 
  Samir GUPTA, United States
IAS 2021 July 18-22

0720211

0720212

0720213

0720214

0720215

0720216